Abstract
Nonsteroidal antiestrogens, discovered in the 1960s, were “morning after pills” in rodents that triggered ovulation in humans. The discovery of selective estrogen receptor modulation (SERM) by nonsteroidal antiestrogens, revolutionized women’s health. There are five FDA approved SERMs that switch on estrogen-like actions, such as building postmenopausal bone, lowering circulating cholesterol and increasing vaginal secretions but switch off uterine stimulation and breast cancer development, representing antiestrogen actions.
| Original language | English (US) |
|---|---|
| Title of host publication | Standardizing Pharmacology |
| Subtitle of host publication | Assays and Hormones Discoveries in Pharmacology: Volume 2 |
| Publisher | Elsevier |
| Pages | 241-244 |
| Number of pages | 4 |
| Volume | 2 |
| ISBN (Electronic) | 9780323855174 |
| DOIs | |
| State | Published - Jan 1 2023 |
Keywords
- Adjuvant therapy for Breast Cancer
- Carl Djerassi
- SERMs
- Steroid Chemistry
- Tamoxifen
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Progress in the chemistry of agents to modulate reproduction. Commentary on The chemical history of the Pill by Carl Djerassi'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS